WILMINGTON, Del., Nov. 2, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions ("TSS"), Titanium Technologies ("TT"), and Advanced Performance Materials ("APM"), today announced its financial results for the third quarter 2026.

Key Third Quarter 2026 Results & Recent Highlights1

- Net Sales of $1.5 billion, up slightly from the prior-year quarter, reflecting an approximately 10% year-over-year pricing increase in TT and 26% year-over-year growth in APM Performance Solutions.

- Net Income attributable to Chemours of $196 million, or $1.29 per diluted share, compared with Net Income attributable to Chemours of $46 million, or $0.31 per diluted share, in the corresponding prior-year quarter.

- Adjusted Net Income2 of $31 million, or $0.21 per diluted share, compared with Adjusted Net Income of $26 million, or $0.17 per diluted share, in the corresponding prior-year quarter.

- Adjusted EBITDA2,3 of $200 million, compared with $189 million in the prior-year quarter, driven by improved pricing in TT and growth in APM Performance Solutions.

- As previously announced, entered into a settlement with the State of North Carolina and 11 local entities to resolve litigation relating to PFAS and other historical discharges from Fayetteville Works, as well as claims of PFAS contamination unrelated to that site, including from the use of AFFF.

- Formally launching Chemours' liquid cooling portfolio, including four two-phase direct-to-chip and one immersion cooling fluid under the Faizeon⢠liquid cooling brand.

- Completed the sale of the Kuan Yin property for total net consideration of ~$340 million, including the remaining land parcel for $56 million of gross proceeds.

"Our third-quarter results demonstrate strong year-over-year performance in TT and APM, reflecting pricing execution in TiO2 and increased demand across Performance Solutions' high-value AI infrastructure including data center and semiconductor end markets," said Denise Dignam, Chemours President and CEO. "We also continued to make meaningful progress under our Pathway to Thrive, including reaching a settlement with the State of North Carolina, driving operational improvements through the Chemours Business System, and closing the sale of the final parcel of land associated with our former Kuan Yin property. While we continue to navigate TSS stationary aftermarket dynamics and a softer macroeconomic environment, we remain focused on disciplined execution of our strategic priorities and the factors within our control to drive long-term returns for shareholders."

Total Chemours

Third quarter 2026 Net Sales were approximately $1.5 billion, an increase of approximately 3% compared with the prior-year quarter. The year-over-year increase in Net Sales was driven by a 5% increase in pricing, partially offset by a 2% decrease in volumes and a slight currency headwind. The pricing increase was primarily driven by previously announced price actions in TT, complemented by a favorable mix shift toward APM Performance Solutions. Lower year-over-year volumes primarily reflected anticipated lower North American stationary AC aftermarket sales of TSS OpteonTM blends compared with elevated demand in the prior-year quarter.

Third quarter 2026 Net Income attributable to Chemours was $196 million, or $1.29 per diluted share, compared with $46 million, or $0.31 per diluted share, in the prior-year quarter. Current-year third-quarter Net Income included the receipt of $150 million related to the PFAS insurance proceeds MOU that was executed in connection with the finalization of the judicial consent order ("JCO") with the State of New Jersey. This was presented as a reduction to Selling, general, and administrative expense. Third quarter Adjusted Net Income increased 19% compared with the prior-year quarter, aligned with trends in Adjusted EBITDA as highlighted below.

Adjusted EBITDA for the third quarter of 2026 was $200 million, compared with $189 million in the prior-year quarter. The increase was driven by pricing momentum in TT and a favorable mix shift toward APM Performance Solutions, partially offset by lower TSS volumes associated with the North American stationary AC aftermarket dynamics noted above and higher costs across each business.

Thermal & Specialized Solutions

TSS segment third quarter 2026 Net Sales were $510 million, a decrease of 9% compared with the prior-year quarter, driven by a 9% decrease in volumes and a slight decrease in price.

The decrease in volumes was primarily attributable to lower North American stationary AC aftermarket sales of TSS Opteon⢠blends compared with elevated demand in the prior-year quarter, which benefited from the initial aftermarket channel fill associated with the stationary AC technology transition under the U.S. AIM Act.

Adjusted EBITDA for the quarter decreased 30% to $136 million, while Adjusted EBITDA Margin decreased eight points to 27%. The decrease in Adjusted EBITDA was primarily driven by the lower OpteonTM stationary aftermarket sales noted above and higher costs incurred during the period.

Sequentially, TSS Net Sales decreased 14%, driven by lower volumes associated with seasonal demand trends in the North American stationary AC aftermarket, as well as a slight currency headwind, partially offset by pricing.

Titanium Technologies

TT segment third quarter 2026 Net Sales were $680 million, an 11% increase compared with the prior-year quarter. The increase was driven by a 10% increase in global pricing and a 1% increase in global volumes, partially offset by a slight currency headwind. Pricing increased across all regions in connection with recent pricing announcements, while global volume growth reflected strength in North America, Latin America, and APAC excluding China that more than offset lower volumes across EMEA and China.

TT segment third quarter 2026 Adjusted EBITDA increased to $85 million from $25 million in the prior-year quarter and Adjusted EBITDA Margin increased by nine points to 13%. The increase in Adjusted EBITDA was primarily driven by the global pricing strength noted above and higher volumes, partially offset by modest cost inflation.

Sequentially, TT segment third quarter 2026 Net Sales increased 3%, driven by a 4% increase in price, reflecting continued execution of recent TiO2 pricing announcements, partially offset by a 1% decrease in global volumes and a slight currency headwind.

Advanced Performance Materials

APM segment third quarter 2026 Net Sales were $337 million, an 8% increase compared with the prior-year quarter. The increase was driven by a 6% increase in price and a 2% increase in volume, partially offset by a slight currency headwind. Performance Solutions Net Sales increased 26%, reflecting continued order book strength and momentum in high-value specialty products serving data center and semiconductor end markets.

APM segment third quarter 2026 Adjusted EBITDA increased 71% to $24 million compared with the prior-year quarter, while Adjusted EBITDA Margin increased two points to 7%. The increase in Adjusted EBITDA was primarily driven by a favorable mix shift toward higher-value Performance Solutions products serving data center and semiconductor end markets, partially offset by higher costs incurred during the period.

Sequentially, APM segment third quarter 2026 Net Sales increased approximately 3%, driven by a 2% increase in price and a 1% increase in volume. Performance Solutions Net Sales increased 8%, reflecting continued order book strength and momentum in high-value specialty products serving data center and semiconductor end markets.

Other Non-Reportable Segment

The Performance Chemicals and Intermediates business in the Company's Other Non-Reportable Segment had Net Sales and Adjusted EBITDA for the third quarter 2026 of $13 million and $1 million, respectively.

Corporate Expenses

Corporate Expenses were $46 million in the third quarter of 2026, an increase of approximately $1 million compared with the prior-year quarter.

Liquidity and Capital Allocation

As of September 30, 2026, consolidated gross debt was $3.9 billion. Debt, net of $698 million in unrestricted4 cash and cash equivalents, was $3.2 billion, resulting in a Net Leverage ratio of approximately 4.3x on a trailing twelve-month Adjusted EBITDA basis. Total liquidity was $1.7 billion, composed of $698 million in unrestricted cash and cash equivalents and $953 million of revolving credit facility capacity, net of outstanding letters of credit.

Operating cash flows for the third quarter of 2026 were $149 million, which includes the aforementioned receipt of $150 million in restricted cash related to the PFAS insurance proceeds MOU in connection with the finalization of the JCO with the State of New Jersey, partially offset by an approximately $100 million use of restricted cash to fund settlement payments associated with the 2025 settlement with the State of New Jersey and approximately $25 million of taxes related to the property sale in Kuan Yin. This is compared with $146 million of operating cash flows in the prior-year quarter.

Capital expenditures for the third quarter of 2026 amounted to $51 million, an increase compared with $41 million in the prior-year quarter.

Free Cash Flows for the third quarter of 2026 were $98 million, compared with $105 million in the third quarter of 2025.

Fourth Quarter 2026 Outlook

In the fourth quarter, the Company expects consolidated Net Sales to decrease in the range of 5% to 10%, sequentially, driven by seasonality in TSS and TT, with consolidated Adjusted EBITDA expected to range between $160 million and $185 million. Corporate Expenses are expected to be approximately $40 million to $45 million. The Company also anticipates capital expenditures to be between $75 million and $85 million, with positive Free Cash Flows.